Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...

A total of 100 patients were identified as receiving at least one 300-mg dose of elemental iron i.v. as iron sucrose. Of these patients, 73 had NDDCKD; the remaining 27 patients had a CL cr of ≥ ...

Emkay Global Financial is bearish on Dr Reddys recommended sell rating on the stock with a target price of Rs 1150 in its ...

The maximum recommended dose of elemental iron i.v. as iron sucrose per infusion is one that would deliver 200 mg of elemental iron. [7] This would necessitate five infusions to achieve the goal ...

Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1s (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after ...

Extending losses for the second session, Dr Reddy’s shares dropped 6.65% to hit a low of ₹1,203.60 on the BSE as investors weighed weak Q3 results.

Clinical trials incorporating IV iron formulations most commonly include iron sucrose or ferric carboxymaltose. The administration of IV iron allows for higher amounts of Fe3+ delivered directly into ...

As many as 38 drug samples manufactured in various drug clusters of the state failed quality parameters in the monthly alert ...

Dr. Reddy's shares are the top losers on the Nifty 50 index today. Out of the 40 analysts that have coverage on Dr. Reddy's, ...

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes HPCL, Indus ...